NCT05019703 2026-04-17Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS StudyM.D. Anderson Cancer CenterPhase 2 Recruiting40 enrolled